title: UTP and ATP increase extracellular signal-regulated kinase 1/2 phosphorylation in bovine chromaffin cells through epidermal growth factor receptor transactivation.
abstract: Adenosine triphosphate (ATP) is coreleased with catecholamines from adrenal medullary chromaffin cells in response to sympathetic nervous system stimulation and may regulate these cells in an autocrine or paracrine manner. Increases in extracellular signal-regulated kinase (ERK) 1/2 phosphorylation were observed in response to ATP stimulation of bovine chromaffin cells. The signaling pathway involved in ATP-mediated ERK1/2 phosphorylation was investigated via Western blot analysis. ATP and uridine 5'-triphosphate (UTP) increased ERK1/2 phosphorylation potently, peaking between 5 and 15 min. The mitogen-activated protein kinase (MAPK/ERK)-activating kinase (MEK) inhibitor PD98059 blocked this response. UTP, which is selective for G-protein-coupled P2Y receptors, was the most potent agonist among several nucleotides tested. Adenosine 5'-O-(3-thio) triphosphate (ATPgammaS) and ATP were also potent agonists, characteristic of the P2Y(2) or P2Y(4) receptor subtypes, whereas agonists selective for P2X receptors or other P2Y receptor subtypes were weakly effective. The receptor involved was further characterized by the nonspecific P2 antagonists suramin and reactive blue 2, which each partially inhibited ATP-mediated ERK1/2 phosphorylation. Inhibitors of protein kinase C (PKC), protein kinase A (PKA), Ca(2+)/calmodulin-dependent protein kinase II (CaMKII), and phosphoinositide-3 kinase (PI3K) had no effect on ATP-mediated ERK1/2 phosphorylation. The Src inhibitor PP2, epidermal growth factor receptor (EGFR) inhibitor AG1478, and metalloproteinase inhibitor GM6001 decreased ATP-mediated ERK1/2 phosphorylation. These results suggest nucleotide-mediated ERK1/2 phosphorylation is mediated by a P2Y(2) or P2Y(4) receptor, which stimulates metalloproteinase-dependent transactivation of the EGFR.
authors.affiliation: University of Nebraska Medical Center, 985800 Nebraska Medical Center, Omaha, NE, 68198-5800, USA.
authors.forename: Toni M
authors.initials: TM
authors.lastname: Luke
authors.forename: Terry D
authors.initials: TD
authors.lastname: Hexum
references.citation: J Cell Biol. 2001 Apr 30;153(3):491-501
references.pmid: 11331301
references.citation: Mol Pharmacol. 2004 Sep;66(3):601-11
references.pmid: 15322252
references.citation: Methods Enzymol. 1983;103:305-12
references.pmid: 6321889
references.citation: J Neurochem. 1995 Nov;65(5):2080-6
references.pmid: 7595493
references.citation: EMBO J. 1997 Dec 1;16(23):7032-44
references.pmid: 9384582
references.citation: Clin Med (Lond). 2002 Jan-Feb;2(1):45-53
references.pmid: 11871639
references.citation: Pharmacol Rev. 2006 Mar;58(1):58-86
references.pmid: 16507883
references.citation: J Biol Chem. 2000 May 5;275(18):13789-92
references.pmid: 10788500
references.citation: J Biol Chem. 1998 Sep 4;273(36):23110-7
references.pmid: 9722539
references.citation: Peptides. 2001 Mar;22(3):439-44
references.pmid: 11287099
references.citation: Nature. 1999 Dec 23-30;402(6764):884-8
references.pmid: 10622253
references.citation: Nature. 1996 Oct 10;383(6600):547-50
references.pmid: 8849729
references.citation: Fed Proc. 1983 Sep;42(12):2923-8
references.pmid: 6136425
references.citation: Cell Physiol Biochem. 2006;18(1-3):123-34
references.pmid: 16914897
references.citation: Brain Res. 2004 Dec 31;1030(2):183-92
references.pmid: 15571668
references.citation: J Biol Chem. 1998 Feb 20;273(8):4695-704
references.pmid: 9468531
references.citation: Biochem Biophys Res Commun. 1997 Oct 9;239(1):287-90
references.pmid: 9345312
references.citation: J Biol Chem. 1998 Jan 30;273(5):2653-60
references.pmid: 9446569
references.citation: Cell Signal. 2002 Aug;14(8):649-54
references.pmid: 12020764
references.citation: Mol Neurobiol. 2005;31(1-3):169-83
references.pmid: 15953819
references.citation: Eur J Pharmacol. 2004 Feb 6;485(1-3):137-40
references.pmid: 14757133
references.citation: FEBS Lett. 1999 Nov 19;461(3):273-6
references.pmid: 10567710
references.citation: J Biol Chem. 2000 Aug 18;275(33):25342-50
references.pmid: 10840035
references.citation: J Biol Chem. 2004 Feb 27;279(9):8212-8
references.pmid: 14670955
references.citation: J Biol Chem. 1996 Aug 9;271(32):19443-50
references.pmid: 8702633
references.citation: Nat Neurosci. 2005 Sep;8(9):1160-8
references.pmid: 16116443